SCHEMBL6947265

SCHEMBL6947265

CCc1ccccc1NC=C1C(=O)N(c2ccc(S(=O)(=O)N(CC)CC)cc2)N=C1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT8 Q9H7Z6 2/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 4/20 0.40
MAPT P10636 6/20 0.39
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
PKM P14618 2/20 0.39
ABCG2 Q9UNQ0 1/20 0.39
PHOSPHO1 Q8TCT1 1/20 0.39
PTGS2 P35354 3/20 0.38
HSP90AA1 P07900 1/20 0.38
MAPK1 P28482 4/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HTT P42858 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6947262 1.00 KAT8 (0.42) KAT8CA1CA2CA9KDM4E
SCHEMBL8015657 0.95 KAT8 (0.41) KAT8CA1CA2CA9KDM4E
SCHEMBL8015654 0.95 KAT8 (0.41) KAT8CA1CA2CA9KDM4E
SCHEMBL6949812 0.88 KMT2A (0.47) KAT8CA1CA2CA9ALDH1A1
SCHEMBL6949810 0.88 KMT2A (0.47) KAT8CA1CA2CA9ALDH1A1
SCHEMBL6949544 0.87 PTGS2 (0.47) KAT8CA1CA2CA9KDM4E
SCHEMBL6949542 0.87 PTGS2 (0.47) KAT8CA1CA2CA9KDM4E
SCHEMBL6952098 0.85 MAPT (0.39) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL6952092 0.85 MAPT (0.39) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL6950175 0.85 KAT8 (0.42) KAT8CA1CA2CA9KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP claimed
CN-1066138-C 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones MERCK PATENT GMBH (DE) 2001-05-23 CN claimed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US claimed
CN-1141291-A 4-(Arylaminomethylene)-2,4-dihydro-3-pyrazolones MERCK PATENT GMBH (DE) 1997-01-29 CN claimed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP claimed
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
CN-1066138-C 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones MERCK PATENT GMBH (DE) 2001-05-23 CN disclosed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed
EP-0930881-A1 PYRAZOLINONES TO TREAT DISTURBANCES OF POTENCY MERCK PATENT GmbH (DE) 1999-07-28 EP disclosed
US-5869516-A 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1999-02-09 US disclosed
WO-1998016224-A1 PYRAZOLINONES TO TREAT DISTURBANCES OF POTENCY MERCK PATENT GMBH (DE) 1998-04-23 WO disclosed
CN-1141291-A 4-(Arylaminomethylene)-2,4-dihydro-3-pyrazolones MERCK PATENT GMBH (DE) 1997-01-29 CN disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed